This site is intended for healthcare professionals only
LoginRegister
Zydus Told To Conduct Phase III Trial in India for Lurbinectedin Injection, BE Study WaivedZydus Told To Conduct Phase III Trial in India for Lurbinectedin Injection, BE Study Waived
18 Medical Device Firms Got Rs 133.95 Cr in Incentives Till FY2024-25: Govt Tells RS18 Medical Device Firms Got Rs 133.95 Cr in Incentives Till FY2024-25: Govt Tells RS
AbbVie Eyes USD 1 Billion Buyout of Mental Health Drugmaker GilgameshAbbVie Eyes USD 1 Billion Buyout of Mental Health Drugmaker Gilgamesh
GSK Raises Outlook After Q2 Beat, Eyes USD 53.44B Sales by 2031GSK Raises Outlook After Q2 Beat, Eyes USD 53.44B Sales by 2031
Pharmacy Colleges in Trouble: Maharashtra Cracks Down on Institutions Failing PCI StandardsPharmacy Colleges in Trouble: Maharashtra Cracks Down on Institutions Failing PCI Standards
Top USFDA vaccine official Vinay Prasad exits agencyTop USFDA vaccine official Vinay Prasad exits agency
Akums Drugs & Pharma appoints Tarun Kapoor as CIOAkums Drugs & Pharma appoints Tarun Kapoor as CIO
Laborate Pharma secures EU-GMP Certification, expands global supply chain capabilitiesNPPA Regulated Prices of 2,295 Essential Drugs Over Five Years, Says Govt
CDSCO Introduces QR Code System for Streamlined Visitor EntryCDSCO Introduces QR Code System for Streamlined Visitor Entry
JnJ seeks USFDA approval for Tremfya label updateJnJ seeks USFDA approval for Tremfya label update
acquisitionZydus completes acquisition of 85.6% stake in Amplitude Surgical
Sanofi earns orphan drug designation for multiple myeloma drugSanofi earns orphan drug designation from USFDA for multiple myeloma drug
X